iMDx Prices $15M Offering at $1.75, a Discount to Its $1.66 Close
IMDX is trading near its 52-week low of $1.85 (10% below the low).
Summary
iMDx priced its previously announced underwritten offering: 8,296,429 shares at $1.75 and pre-funded warrants for up to 275,000 shares at $1.7499, for roughly $15M gross before expenses. The pricing follows the launch disclosed the prior evening with Lake Street Capital Markets as underwriter, and closing is expected on or about Nov. 18, 2026. The deal is large relative to a company that posted a $11.3M quarterly loss on just $239K of revenue and held $17.8M in cash with going-concern language — this raise buys time but dilutes heavily. An underwriter option covers up to 1,285,714 additional shares, which would add further dilution if exercised. Watch the Nov. 18 close and any exercise of the greenshoe.
At the time of this announcement, IMDX was trading at $1.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $60.9M. The 52-week trading range was $1.85 to $7.92. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.